These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10747836)
21. Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania. Lyamuya EF; Nyanda P; Mohammedali H; Mhalu FS J Trop Med Hyg; 1992 Oct; 95(5):335-8. PubMed ID: 1404556 [TBL] [Abstract][Full Text] [Related]
22. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Frean JA; Arntzen L; Capper T; Bryskier A; Klugman KP Antimicrob Agents Chemother; 1996 Nov; 40(11):2646-7. PubMed ID: 8913481 [TBL] [Abstract][Full Text] [Related]
23. [Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain]. Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI Antibiot Khimioter; 2004; 49(1):17-21. PubMed ID: 15164519 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague. Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069 [TBL] [Abstract][Full Text] [Related]
25. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice. Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542 [TBL] [Abstract][Full Text] [Related]
26. [Effect of several antibiotics and their combination with prodigiozan on Y. pestis EV, engulfed by macrophages]. Popova GO; Vinidchenko NN; Mikhalevich RV; Sokolova MT; Makarovskaia LN Antibiotiki; 1977 Apr; 22(4):348-53. PubMed ID: 883789 [TBL] [Abstract][Full Text] [Related]
27. [Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen]. Samokhodkina ED; Shcherbaniuk AI; Ryzhko IV; Tsuraeva RI; Skalyga EIu Antibiot Khimioter; 2002; 47(3):26-9. PubMed ID: 16127904 [TBL] [Abstract][Full Text] [Related]
28. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague. Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322 [TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of effectivity of bacteriological examination and antibody neutralization reaction during the action of streptomycin on the plague microbe. Aparin GP J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):257-62. PubMed ID: 5529576 [No Abstract] [Full Text] [Related]
30. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in new Mexico, 1985-1999. Boulanger LL; Ettestad P; Fogarty JD; Dennis DT; Romig D; Mertz G Clin Infect Dis; 2004 Mar; 38(5):663-9. PubMed ID: 14986250 [TBL] [Abstract][Full Text] [Related]
31. F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy. Chanteau S; Rabarijaona L; O'Brien T; Rahalison L; Hager J; Boisier P; Burans J; Rasolomaharo M Trans R Soc Trop Med Hyg; 1998; 92(5):572-3. PubMed ID: 9861385 [No Abstract] [Full Text] [Related]
32. Bubonic plague. Morris JT; McAllister CK South Med J; 1992 Mar; 85(3):326-7. PubMed ID: 1546359 [TBL] [Abstract][Full Text] [Related]
33. Antibiotics in the treatment of bubonic and pneumonic plague in man. SMADEL JE; WOODWARD TE; AMIES CR; GOODNER K Ann N Y Acad Sci; 1952 Dec; 55(6):1275-84. PubMed ID: 13139207 [No Abstract] [Full Text] [Related]
34. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478 [TBL] [Abstract][Full Text] [Related]
35. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))]. Ryzhko IV; Trishina AV; Verkina LM Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421 [TBL] [Abstract][Full Text] [Related]
36. High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection. Ponnusamy D; Fitts EC; Sha J; Erova TE; Kozlova EV; Kirtley ML; Tiner BL; Andersson JA; Chopra AK Infect Immun; 2015 May; 83(5):2065-81. PubMed ID: 25754198 [TBL] [Abstract][Full Text] [Related]
37. [In vitro and in vivo effects of trimethoprim-sulfamethoxazole on Yersinia pestis]. Nguyên-Van-Ai ; Nguyên-Duc-Hanh ; Pham-Van-Diên ; Nguyên-Van-Lê Bull Soc Pathol Exot Filiales; 1972; 65(6):759-64. PubMed ID: 4679265 [No Abstract] [Full Text] [Related]
38. New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Andersson JA; Fitts EC; Kirtley ML; Ponnusamy D; Peniche AG; Dann SM; Motin VL; Chauhan S; Rosenzweig JA; Sha J; Chopra AK Antimicrob Agents Chemother; 2016 Jun; 60(6):3717-29. PubMed ID: 27067323 [TBL] [Abstract][Full Text] [Related]
39. Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry. Steinberger-Levy I; Zahavy E; Cohen S; Flashner Y; Mamroud E; Aftalion M; Gur D; Ber R Adv Exp Med Biol; 2007; 603():339-50. PubMed ID: 17966430 [TBL] [Abstract][Full Text] [Related]